HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Van Nostrand, W. E. Articles by Cunningham, D. D. Search for Related Content PubMed PubMed Citation Articles by Van Nostrand, W. E. Articles by Cunningham, D. D. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 17, 9591-9594, Jun, 1990

Immunopurification and protease inhibitory properties of protease nexin- 2/amyloid beta-protein precursor

WE Van Nostrand, SL Wagner, JS Farrow and DD Cunningham
Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine 92717.

Protease nexin-2 (PN-2) is a protease inhibitor that is synthesized and secreted by a variety of extravascular cells including human fibroblasts. It forms sodium dodecyl sulfate-stable complexes with trypsin, the epidermal growth factor binding protein and the gamma- subunit of nerve growth factor. Recently we reported that PN-2 is the secreted form of the amyloid beta-protein precursor (APP) and is a potent inhibitor of chymotrypsin. Here we describe a two-step procedure to purify PN-2/APP using a monoclonal antibody immunoaffinity column. We also quantitated the protease inhibitory properties of purified PN- 2/APP on a number of serine proteases. PN-2/APP was a potent inhibitor of coagulation factor XIa with a Ki = 2.9 x 10(-10). The inhibition of factor XIa by PN-2/APP was augmented by heparin and resulted in a Ki = 5.5 x 10(-11) M. Trypsin and chymotrypsin were also effectively inhibited with a Ki = 4.2 x 10(-10) and 1.6 x 10(-9), respectively. PN- 2/APP also inhibited the epidermal growth factor binding protein, the gamma-subunit of nerve growth factor, and chymase and plasmin to a lesser extent. In view of recent findings that PN-2/APP is contained in alpha-granules of platelets and is secreted upon platelet activation, the potent inhibition of factor XIa suggests that PN-2/APP may play a regulatory role in the coagulation pathway at vascular wound sites. In addition, these studies define biochemical activities of PN-2/APP which may be involved in regulating proteases that lead to the generation and deposition of the beta-protein in neurodegenerative lesions associated with Alzheimer's disease and Down's syndrome.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				O. Salomon, D. M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn Reduced incidence of ischemic stroke in patients with severe factor XI deficiency Blood, April 15, 2008; 111(8): 4113 - 4117. [Abstract] [Full Text] [PDF]

				F. Xu, M. L. Previti, and W. E. Van Nostrand Increased Severity of Hemorrhage in Transgenic Mice Expressing Cerebral Protease Nexin-2/Amyloid {beta}-Protein Precursor Stroke, September 1, 2007; 38(9): 2598 - 2601. [Abstract] [Full Text] [PDF]

				D. L. Pedicord, D. Seiffert, and Y. Blat Feedback activation of factor XI by thrombin does not occur in plasma PNAS, July 31, 2007; 104(31): 12855 - 12860. [Abstract] [Full Text] [PDF]

				P. F. Neuenschwander, S. R. Williamson, A. Nalian, and K. J. Baker-Deadmond Heparin Modulates the 99-Loop of Factor IXa: EFFECTS ON REACTIVITY WITH ISOLATED KUNITZ-TYPE INHIBITOR DOMAINS J. Biol. Chem., August 11, 2006; 281(32): 23066 - 23074. [Abstract] [Full Text] [PDF]

				F. Xu, J. Davis, J. Miao, M. L. Previti, G. Romanov, K. Ziegler, and W. E. Van Nostrand Protease nexin-2/amyloid {beta}-protein precursor limits cerebral thrombosis PNAS, December 13, 2005; 102(50): 18135 - 18140. [Abstract] [Full Text] [PDF]

				D. Navaneetham, L. Jin, P. Pandey, J. E. Strickler, R. E. Babine, S. S. Abdel-Meguid, and P. N. Walsh Structural and Mutational Analyses of the Molecular Interactions between the Catalytic Domain of Factor XIa and the Kunitz Protease Inhibitor Domain of Protease Nexin 2 J. Biol. Chem., October 28, 2005; 280(43): 36165 - 36175. [Abstract] [Full Text] [PDF]

				H.-H. Chen, C. P. Vicente, L. He, D. M. Tollefsen, and T.-C. Wun Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants Blood, May 15, 2005; 105(10): 3902 - 3909. [Abstract] [Full Text] [PDF]

				P Connor and B J Hunt Cerebral haemostasis and antiphospholipid antibodies Lupus, December 1, 2003; 12(12): 929 - 934. [Abstract] [PDF]

				M. Gralle, M. M. Botelho, C. L. P. de Oliveira, I. Torriani, and S. T. Ferreira Solution Studies and Structural Model of the Extracellular Domain of the Human Amyloid Precursor Protein Biophys. J., December 1, 2002; 83(6): 3513 - 3524. [Abstract] [Full Text] [PDF]

				W. E. Van Nostrand, J. P. Melchor, D. M. Keane, S. M. Saporito-Irwin, G. Romanov, J. Davis, and F. Xu Localization of a Fibrillar Amyloid beta -Protein Binding Domain on Its Precursor J. Biol. Chem., September 20, 2002; 277(39): 36392 - 36398. [Abstract] [Full Text] [PDF]

				S. K Ohri, R. Parratt, T. White, J. Becket, J. J Brannan, B. J Hunt, and K. M Taylor A genetically engineered human Kunitz protease inhibitor with increased kallikrein inhibition in an ovine model of cardiopulmonary bypass Perfusion, May 1, 2001; 16(3): 199 - 206. [Abstract] [PDF]

				S.-R. Hwang, B. Steineckert, S. Yasothornsrikul, C. A. Sei, T. Toneff, J. Rattan, and V. Y. H. Hook Molecular Cloning of Endopin 1, a Novel Serpin Localized to Neurosecretory Vesicles of Chromaffin Cells. INHIBITION OF BASIC RESIDUE-CLEAVING PROTEASES BY ENDOPIN 1 J. Biol. Chem., November 26, 1999; 274(48): 34164 - 34173. [Abstract] [Full Text] [PDF]

				V. Y. H. Hook, C. Sei, S. Yasothornsrikul, T. Toneff, Y.-H. Kang, S. Efthimiopoulos, N. K. Robakis, and W. Van Nostrand The Kunitz Protease Inhibitor Form of the Amyloid Precursor Protein (KPI/APP) Inhibits the Proneuropeptide Processing Enzyme Prohormone Thiol Protease (PTP). COLOCALIZATION OF KPI/APP AND PTP IN SECRETORY VESICLES J. Biol. Chem., January 29, 1999; 274(5): 3165 - 3172. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. M. Scandura, W. E. Van Nostrand, and P. N. Walsh The Mechanism by Which Heparin Promotes the Inhibition of Coagulation Factor XIa by Protease Nexin-2 J. Biol. Chem., October 17, 1997; 272(42): 26139 - 26144. [Abstract] [Full Text] [PDF]

				I. M. Lang, K. M. Moser, and R. R. Schleef Expression of Kunitz Protease Inhibitor–Containing Forms of Amyloid ß-Protein Precursor Within Vascular Thrombi Circulation, December 1, 1996; 94(11): 2728 - 2734. [Abstract] [Full Text]

				L. Ho, K.-i. Fukuchi, and StevenG. Younkin The Alternatively Spliced Kunitz Protease Inhibitor Domain Alters Amyloid beta Protein Precursor Processing and Amyloid beta Protein Production in Cultured Cells J. Biol. Chem., November 29, 1996; 271(48): 30929 - 30934. [Abstract] [Full Text] [PDF]

				S. M. Saporito-Irwin and W. E. Van Nostrand Coagulation Factor XIa Cleaves the RHDS Sequence and Abolishes the Cell Adhesive Properties of the Amyloid beta-Protein J. Biol. Chem., November 3, 1995; 270(44): 26265 - 26269. [Abstract] [Full Text] [PDF]

				F. Mahdi, W. E. Van Nostrand, and A. H. Schmaier Protease Nexin-2/Amyloid beta-Protein Precursor Inhibits Factor Xa in the Prothrombinase Complex J. Biol. Chem., October 6, 1995; 270(40): 23468 - 23474. [Abstract] [Full Text] [PDF]

				W. E. Van Nostrand, A. H. Schmaier, R. S. Siegel, S. L. Wagner, and W. C. Raschke Enhanced Plasmin Inhibition by a Reactive Center Lysine Mutant of the Kunitz-type Protease Inhibitor Domain of the Amyloid beta-Protein Precursor J. Biol. Chem., September 29, 1995; 270(39): 22827 - 22830. [Abstract] [Full Text] [PDF]

				L. Gregori, C. Fuchs, M. E. Figueiredo-Pereira, W. E. Van Nostrand, and D. Goldgaber Amyloid beta-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro J. Biol. Chem., August 25, 1995; 270(34): 19702 - 19708. [Abstract] [Full Text] [PDF]

				D. J. Knauer, D. Majumdar, P.-C. Fong, and M. F. Knauer SERPIN Regulation of Factor XIa. THE NOVEL OBSERVATION THAT PROTEASE NEXIN 1 IN THE PRESENCE OF HEPARIN IS A MORE POTENT INHIBITOR OF FACTOR XIa THAN C1 INHIBITOR J. Biol. Chem., November 22, 2000; 275(48): 37340 - 37346. [Abstract] [Full Text] [PDF]

				J. Santiago-Garcia, J. Mas-Oliva, T. L. Innerarity, and R. E. Pitas Secreted Forms of the Amyloid-beta Precursor Protein Are Ligands for the Class A Scavenger Receptor J. Biol. Chem., August 10, 2001; 276(33): 30655 - 30661. [Abstract] [Full Text] [PDF]